{"id":"NCT01984684","sponsor":"Melinta Therapeutics, Inc.","briefTitle":"Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind, Active Controlled Study to Evaluate the Efficacy + Safety of IV + Oral Delafloxacin Compared With Vancomycin + Aztreonam in Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-05","primaryCompletion":"2015-12","completion":"2016-01","firstPosted":"2013-11-15","resultsPosted":"2017-08-28","lastUpdate":"2017-11-17"},"enrollment":850,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Skin and Subcutaneous Tissue Bacterial Infections","Skin Structures and Soft Tissue Infections"],"interventions":[{"type":"DRUG","name":"delafloxacin","otherNames":["RX-3341"]},{"type":"DRUG","name":"vancomycin","otherNames":[]},{"type":"DRUG","name":"aztreonam","otherNames":[]}],"arms":[{"label":"Delafloxacin","type":"EXPERIMENTAL"},{"label":"Vancomycin plus Aztreonam","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the effects of Delafloxacin versus Vancomycin plus Aztreonam in the treatment of patients with acute bacterial skin and soft tissue infections.","primaryOutcome":{"measure":"Objective Response of â‰¥20% Reduction in Lesion Erythema Area Compared to Baseline at 48 to 72 Hours After Initiation of Treatment as Determined by Digital Measurements of the Leading Edge.","timeFrame":"48 to 72 hrs after starting treatment","effectByArm":[{"arm":"Delafloxacin","deltaMin":354,"sd":null},{"arm":"Vancomycin Plus Aztreonam","deltaMin":344,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":94,"countries":["United States","Argentina","Brazil","Bulgaria","Chile","Estonia","Georgia","Hungary","Latvia","Mexico","Moldova","Peru","Romania","Slovakia","South Korea","Taiwan"]},"refs":{"pmids":["30349845","29518178","28630189"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":16,"n":417},"commonTop":["Nausea","Diarrhea"]}}